Jointly sponsored by the
Regional Training and Medical Consultation Centers

 Practical Implementation of the 2016 ATS/CDC/IDSA Treatment
Of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies

 Friday, February 03, 2017
11:00 a.m. – 12:30 p.m. (Pacific Time),
12:00 p.m.  1:30 p.m. (Mountain Time),
1:00 p.m.  2:30 p.m. (Central Time),
2:00 p.m.  3:30 p.m. (Eastern Time)

A National Webinar
The 2nd webinar in a 2-part series

 

Registration Deadline:
Registration will be on a first come, first served basis until the webinar capacity is reached.  Deadline to register is January 27, 2017.

Cost:
There is no fee for this training.

Target Audience:
This training is intended for physicians, nurses, and other health professionals who treat and case manage patients with active TB. This training opportunity is available to a national audience.

Description:
This 90minute webinar will provide practical implications of the recommendations in the “2016 Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug Susceptible Tuberculosis” to guide clinical decision making. This webinar will discuss implementation of the guidelines from various TB program settings.

Faculty:

Dave Ashkin, MD Medical Director Southeastern National Tuberculosis Center (SNTC) Gainesville, FL	Peter Davidson, PhD Tuberculosis Controller & Program Manager Michigan Department of Health & Human Services Lansing, MI	Susan Dorman, MD Associate Professor Johns Hopkins University Baltimore, MD	Alfred Lardizabal, MD Executive Director Global Tuberculosis Institute at  Rutgers; The State University of  New Jersey Newark, NJ
Phil LoBue, MD Director, Division of Tuberculosis Elimination Centers for Disease Control and Prevention Atlanta, GA	Barbara Seaworth, MD Medical Director & Professor of Medicine Heartland National TB Center, UT Health Northeast San Antonio, TX	John Wilson, MD Consultant, Physician Infecous Diseases; Medical Director of TB consultations Mayo Clinic TB Center Mayor Clinic Rochester, MN

 

Continuing Education: 

CNE:
The Centers for Disease Control and Prevention is accredited as a provider for Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. 

CME:
The University of Texas Health Science Center at Tyler is accredited by the Texas Medical Association to sponsor continuing medical education for physicians.
Continuing education for this activity is pending, see final announcement for details.

CLICK HERE TO ACCESS THE 1ST OF THIS 2 PART SERIES:
2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar